Cost effectiveness analysis of low dose computed tomography lung cancer screening in Chinese population.

ABSTRACT: This study evaluated the economic benefits, optimal starting age, and most appropriate screening strategy for low-dose computed tomography (LDCT) lung cancer screening in the Chinese population from the perspective of the Chinese healthcare system. A Markov model was developed using previously published epidemiological and cost data from China to simulate the screening process for individuals aged 40 to 80. The analysis considered different starting ages (40, 45, 50, and 55 years) and screening intervals (annually, every two years, and every three years), resulting in 12 screening strategies and one no-screening strategy. The primary outcome was the incremental cost-effectiveness ratio (ICER). To validate the model, predicted lung cancer incidence rates were compared with actual incidence

SUBMITTER: Yao Y 

PROVIDER: S-EPMC12559212 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature